Loading...
•
Jun 30, 2022
Akoya Q2 2022 Earnings Report
Akoya reported strong financial performance with record revenue and system placements.
Key Takeaways
Akoya Biosciences reported a 37% increase in revenue compared to the prior year period. The company sold 60 instruments, an increase of 94% from the prior year period. They are raising full year 2022 revenue guidance range to $71-74 million.
Total revenue was $17.9 million, an increase of 37% year-over-year.
Product revenue was $14.2 million, an increase of 33% year-over-year.
Services and other revenue totaled $3.7 million, an increase of 54% year-over-year.
60 instruments were sold, an increase of 94% year-over-year.
Revenue by Segment
Forward Guidance
The company is raising its full year 2022 revenue guidance range to $71-74 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...